Veritable’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,178
| Closed | -$1.56M | – | 623 |
|
|
2023
Q2 | $1.56M | Sell |
2,178
-103
| -5% | -$74K | 0.02% | 280 |
|
|
2023
Q1 | $1.87M | Buy |
2,281
+196
| +9% | +$161K | 0.03% | 251 |
|
|
2022
Q4 | $1.5M | Buy |
2,085
+56
| +3% | +$40.4K | 0.03% | 276 |
|
|
2022
Q3 | $1.4M | Buy |
2,029
+158
| +8% | +$109K | 0.03% | 277 |
|
|
2022
Q2 | $1.11M | Sell |
1,871
-40
| -2% | -$23.6K | 0.02% | 346 |
|
|
2022
Q1 | $1.34M | Buy |
1,911
+51
| +3% | +$35.6K | 0.02% | 331 |
|
|
2021
Q4 | $1.18M | Buy |
1,860
+146
| +9% | +$92.2K | 0.02% | 368 |
|
|
2021
Q3 | $1.04M | Sell |
1,714
-4
| -0.2% | -$2.42K | 0.02% | 373 |
|
|
2021
Q2 | $960K | Buy |
1,718
+53
| +3% | +$29.6K | 0.02% | 387 |
|
|
2021
Q1 | $788K | Sell |
1,665
-57
| -3% | -$27K | 0.01% | 405 |
|
|
2020
Q4 | $832K | Buy |
1,722
+16
| +0.9% | +$7.73K | 0.02% | 385 |
|
|
2020
Q3 | $955K | Sell |
1,706
-32
| -2% | -$17.9K | 0.02% | 328 |
|
|
2020
Q2 | $1.08M | Sell |
1,738
-81
| -4% | -$50.5K | 0.02% | 290 |
|
|
2020
Q1 | $888K | Buy |
1,819
+206
| +13% | +$101K | 0.02% | 330 |
|
|
2019
Q4 | $606K | Buy |
1,613
+58
| +4% | +$21.8K | 0.01% | 485 |
|
|
2019
Q3 | $431K | Sell |
1,555
-2
| -0.1% | -$554 | 0.01% | 547 |
|
|
2019
Q2 | $487K | Sell |
1,557
-504
| -24% | -$158K | 0.01% | 506 |
|
|
2019
Q1 | $846K | Sell |
2,061
-208
| -9% | -$85.4K | 0.02% | 375 |
|
|
2018
Q4 | $847K | Buy |
2,269
+282
| +14% | +$105K | 0.02% | 343 |
|
|
2018
Q3 | $803K | Buy |
1,987
+3
| +0.2% | +$1.21K | 0.02% | 383 |
|
|
2018
Q2 | $684K | Sell |
1,984
-515
| -21% | -$178K | 0.01% | 424 |
|
|
2018
Q1 | $861K | Buy |
2,499
+242
| +11% | +$83.4K | 0.02% | 362 |
|
|
2017
Q4 | $849K | Sell |
2,257
-440
| -16% | -$166K | 0.02% | 370 |
|
|
2017
Q3 | $1.21M | Buy |
2,697
+372
| +16% | +$166K | 0.03% | 303 |
|
|
2017
Q2 | $1.14M | Buy |
2,325
+122
| +6% | +$59.9K | 0.03% | 321 |
|
|
2017
Q1 | $854K | Sell |
2,203
-87
| -4% | -$33.7K | 0.02% | 358 |
|
|
2016
Q4 | $841K | Buy |
2,290
+232
| +11% | +$85.2K | 0.02% | 344 |
|
|
2016
Q3 | $827K | Buy |
2,058
+342
| +20% | +$137K | 0.02% | 355 |
|
|
2016
Q2 | $599K | Buy |
1,716
+80
| +5% | +$27.9K | 0.02% | 403 |
|
|
2016
Q1 | $590K | Sell |
1,636
-458
| -22% | -$165K | 0.02% | 397 |
|
|
2015
Q4 | $1.14M | Buy |
2,094
+408
| +24% | +$222K | 0.03% | 281 |
|
|
2015
Q3 | $784K | Buy |
1,686
+78
| +5% | +$36.3K | 0.02% | 338 |
|
|
2015
Q2 | $820K | Sell |
1,608
-4,463
| -74% | -$2.28M | 0.02% | 343 |
|
|
2015
Q1 | $2.74M | Buy |
6,071
+12
| +0.2% | +$5.42K | 0.06% | 214 |
|
|
2014
Q4 | $2.49M | Sell |
6,059
-75
| -1% | -$30.8K | 0.05% | 231 |
|
|
2014
Q3 | $2.21M | Buy |
6,134
+12
| +0.2% | +$4.33K | 0.05% | 244 |
|
|
2014
Q2 | $1.73M | Buy |
6,122
+1,005
| +20% | +$284K | 0.04% | 280 |
|
|
2014
Q1 | $1.54M | Sell |
5,117
-72
| -1% | -$21.6K | 0.03% | 296 |
|
|
2013
Q4 | $1.43M | Buy |
5,189
+565
| +12% | +$155K | 0.03% | 310 |
|
|
2013
Q3 | $1.45M | Buy |
4,624
+349
| +8% | +$109K | 0.03% | 298 |
|
|
2013
Q2 | $961K | Buy |
+4,275
| New | +$961K | 0.02% | 403 |
|